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Since first reported, percutaneous transluminal coronary 
widespread acceptance and use. 
percutaneous coronary revascular- 
ticipated inthe United States in the 
cumnt calender year. Despite the increasing number of 
coronary angioplasty procedures performed, limitations re- 
main. Primary success rates approximate 90%, but ~40% of 
tients develop recurrence. The ability to M-stratify pa- 
tients for long-term event-free survival fter coronary angio- 
plasty would have impc?rtant clinical value in guiding 
follow-up care and could potentially be of benefit n deter- 
mining suitability for percutaneous revascularization versus 
surgical revacularization. Most previous tudies have ad- 
dressed short-term outcome and risks after coronary angio- 
plasty (l-6). No recent studies have evaluated long-term 
survival or attempted to assess risk indexes. 
To risk-stratify patients for probability of long-term 
event-free survival after elective coronary angioplasty, we 
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performed multivariate analysis of 19 clinical and anatomic 
variables as predictors ofevent-free survival in 5, con- 
secutive patients. Four thousand patients were d to 
develop a model for predicting long-term survival free of 
myocardial infarction, bypass urgery, repeat coronary an- 
gioplasty or death after elective coronary angioplasty. 
model was tested and validated with the remaining 1 
patients. Finally, a simplified version of the model was 
developed tofacilitate risk stratification after coronary an- 
gioplasty. 
We used a prospectively collected computerized data 
base to identify 5,VOO consecutive patients undergoing elec- 
tive coronary angioplasty at our institution between Decem- 
ber 1980 and September 1988. Patients undergoing coronary 
angioplasty for acute ischemic events were excluded from 
the analysis. The data base contained both clinical and 
procedural information on all patients. Incomplete data for 
some of the variables were obtained retrospectively b
review of the medical records. Variables for which data had 
not been collected for the duration of the registry or was 
largely incomplete were not evaluated (e.g., smoking histo- 
ry). For the purpose of our analysis, lesion morphologic 
characteristics were not included because they had not been 
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erate or severe dysfunc 
y cause. overt-free 
with incomplete follow-up data, 78 (1.6% of the 
were lost to follow-up, and 52 (1%) bad no 
follow-up after their initial hospital discharge. Patients with- 
out follow-up were censored at the time of hospital dis- 
charge, and patients lost to follow-up were censored at the 
date of last follow-up. The majority of patients with no 
follow-up (71%) were from foreign countries. The survival 
time of patients experiencing multiple vents was calculated 
as the time from the initial procedure tothe first event. 
S~t~~~~l analysis. S time mates were calcu- 
lated by the method of and ier, and statistical 
comparisons between survival curves were done using the 
log-rank test (7). The significance of each of tbe 19 anatomic 
and clinical variables was assessed using the Cox discrete 
proportional hazards models (8). Multivariate analyses using 
Cox models were done to determine which factors were 
significantly associated 4th overall survival, survival free of 
individual events (myocardial infarction, coronary bypass 
surgery, repeat coronary angioplasty) and event-free sur- 
the log (-log) survivor 
nal hazards score’ 
atients. First, the prop0 
from the m~lt~variate 
survival distributions among the three groups. The ability of 
the model developed inthe test set to classify patients into 
categories of risk in an independent 
by using the “c index,” as described by Narrell et al. (BO). 
This index estimates the probability hat, for a given rair of 
patients chosen at random, the one with lower estimated risk 
of death actually lived longer. Values near 1 indicate 
model successfully determines which patients will 
better prognosis. As a second measure of the adequacy of
the model, the proportional b 
the training set was used to di 
groups. Survival curves for th 
determine whether the predic 
survival in the test set. Third, an “R index,” which repre- 
sents the proportion ofthe log-likelihood f a perfect model 
(zero) penalized for the number of factors in the model, was 
assessed. The R index for a model with p covariates is the 
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1. Baseline Characteristics of 5,ooO Patients Undergoing 
Elective Angioplasty 
No. of Pts % 
Male 3,726 75 
Female I.214 25 
Age 
s@yr 2,867 57 
61-70 yr 1.5% 32 
sm yr 537 II 
ccs class 
iI 
111 
IV 
Diabetes mellitus 
Family history of atheroosclcrosis 
History ofhypedipidemh 
HiWry of hypertension 
Previous bypass surgery 
Revious myocardial infarclion 
Previous PTCA 
LeR venlriculer function 
Normal/mild dysfunclion 
Moderakkeven dysfuncrion 
Exlenl of disease 
Single vessei 
Double vessel 
Triple vessel 
Artery involvement 
LAD 
LCX 
RCA 
Saphenous vein graR 
Oulcome of initial ITCA 
Success 
Failure 
927 19 
1,775 35 
I.208 24 
1.090 22 
689 14 
2,635 53 
292 6 
1.285 26 
2,217 44 
673 14 
1,742 35 
153 3 
4.445 89 
555 II 
2.132 54.6 
1.581 31.6 
687 13.8 
2,576 52 
I.364 27 
1.721 34 
136 3 
4.461 93 
333 7 
CCS = Canedian Cardiovascular So&y; LAD = IeR anterior descending 
coronary Fiery; LCx 22 IeR circumllex artery: PITA = percuraneous 
Iran&i&al comply ‘oplasly; pts = patienls. 
root of(LLmQ&, - Zp)I(LL,, - LL,+J. An R index 
of 1 would indicate aperfectly predictive model. 
After validation, the data sets were combined, and the 
regression coefficients for the final multivariate model were 
reestimated and risk groups redefined. These regression 
ClX s were then used to develop asimplified model in 
the it would facilitate use of the scoring system. The 
regression coefficients were adjusted to whole numbers to 
simplifjj calculations, and risk categories were redefined. 
The loss of precision from rounding was tested graphically 
erlaying the survival plots derived from the rounded 
unrounded terms and by comparing the log-rank statis- 
tics for the two models. The predictive accuracy ofthe final 
model was assessed using the c index. 
Baseline characteristics of the 5,000 patients are listed in 
Table 1. The median age of the population was 59 years 
Table 2. Long-Term Event-Free Survival After Elective 
Percutaneous ~ra~slM~ima~ Coronary A~g~o~~as~y 
Time 
Estimated Proportion No. of Pts 
Surviving Even! Free SE at Risk 
1 Yr 0.711 0. 3,499 
3 yr 0.613 0. 2, 
5 vr 0.522 0. 
Fts = patients. 
in-hospital events occu 
1 year and 91 .O% at 5 years. 
survival for patients after electiv 
3 and j years. Of the 23.9% of patient 
Multivariate analysis using the Cox proportional hazards 
models was stormed the training set of 4, 
to obtain regression toe ients for each of th 
and a proportional ha score was calculated. The pro- 
portional hazards score was used to de t&e patients into 
three subgroups with an approxim y equal number of 
failures in each group. The model fit the data well on the 
basis of the distinct Kaplan- er event-free survival distri- 
butions (p < 0.0001). When equation was applied to the 
test set, the event-free survival curves were also significantly 
different (p < 0 1). thus demonstrating themodel’s ability 
to classify pati into distinct risk groups in an indepen- 
dent subset. The model’s predictive accuracy was also 
adequate, asevidenced by a c index of 0.75 and an R index 
of 0.98. 
Once the equation was validated, final estimates bdsed on 
the entire population were obtained. Factors associ 
an adverse outcome in the multivariate analysis of 
patients are listed in Table 4. The proportional hazards score 
(Y)forthetotalpopulationisY =O.O54(ifage61 to70years)+ 
0.150 (if age 270 years) + 0.270 (extent of disease - I) + 
0.114 (functional c ass - I) + 0.292 (if previous coronary 
angioplasty) + 0.129 (if male) + 0. I 18 (if history of diabetes 
mellitus) + 0.082 (if history of hypertension) + 0.179 (if 
history of congestive heart failure). 
JAW Vol. 24, No, 1 
61-70 yr 
270 yr 
Extent of disease? 
CCS classificationt 
Qiabetes mellitus 
severe left ventrisular ~ysfunst~on 
0.0345 NS NS NS 
NS NS NS NS 
determ~oed from Figure D. an 
score calculated for an i 
scores of each of the variables. e we~gbted values can be 
added for an individual patient and compared with each of 
the categories: “‘low risk” is a score 54; “moderate ris 
. Factors Predicting Adverse Outcome 
Multivariate Analysis of 5,000 Patients 
Risk 95% Confidence 
Characteristic Ratio Interval 
Male gender 1.14 1.03-1.26 
Age 
61-70 yr 1.06 0.96-1.16 
>70 yr 1.16 1.02-1.32 
Extent of disease 1.31 1.24-1.39 
CCS classification 1.12 1.07-1.17 
Diabetes mellitus 1.13 1.00-I .27 
Congestive heart failure 1.20 1.01-1.41 
Hypertension 1.09 1.00-1.18 
Previous PTCA 1.34 1.07-1.68 
Abbreviations as in Table I. 
Regression 
Coelkient 
0.129 
0.054 
0.150 
0.270 
0.114 
0.118 
0.179 
0.082 
0.292 
ultiple studies have documented both clinical and an- 
giograp~ic variables related to procedural outcome after 
sty (1,3,4). Other studies have assessed 
with restenosis (5,6). 
few studies have evaluated ion~term event-free survival 
after coronary angioplasty (2,3,12-84). In the current study, 
re I!. Baseline event-free survival rate for patients inthe lowest 
ategory for all risk factors. PTCA = percutaneous transluminal 
coronary angioplasty. 
0 1: 24 36 46 60 72 
Months Following PTCA 
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5. Simplified Method for Risk Stratification f Long-Term 
tcome After Elective Coronary Angioplasty 
Weighted 
cbamcteristic SCOIX 
Tripk-vessel disease 
Hypeftensioa 
ccs class 
II 
III 
i+WbJS PTCA 
--- 
edian 
Total score Event- 
Free 
Risk Group ssore) Survival 
LOW 
Moderate 
Hiti 
Abbreviations as in Table 1. 
s4 8.3 yr 
5 to 7 5.3 yr 
et? 3.1 yr 
clinical and anatomic variables were assessed in a muitivari- 
ate analysis and used to develop and validate a statistical 
model to predict event-free survival 
plasty. The model was then used to de 
scoring system to facilitate risk stratification f long-term 
outcome after coronary angioplasty. 
The information may be useful in 
ment and follow-up of patients to 
lected ata on long-term results after coronary angioplasty 
and bypass urgery could be used to triage patients for 
appropriate r vascularixation procedures. Patients identified 
before the procedure as at high risk for recurrent cardiac 
events could be considered for alternative forms of therapy. 
If no alternative options exist, diligent postprocedural 
follow-up would be warranted. Ultimately, more attentive 
follow-up in high risk patients has the potential to decrease 
the number of recurrent cardiac events, most importantly 
myw infarction and death. Unfortunately, not all of 
the ri tors have been identified, as shown in Figure I. 
Patients in the lowest category of each risk factor continued 
to have events. Despite the laae cohort of patients used in 
the present study and the large number of variables as- 
sessed, we were unable to further isk-stratify the patients 
versus Iate events. Clinical and angiogmphic pre- 
dictors of acute ischemic events after coronary angioplasty 
Table 6. Estimated Event-Free Survival and Event 
various Risk Groups - 
Outcome 1 YP 
Event free (%I 
Low risk (n = 1,934) 16.3 
Moderate risir (n = 2,205) 69.0 
High risi (n = 493) 64.4 
Myocardial infarction (%I 
Low Pi& 1.4 
Moderate risk 2.2 
2.5 
Bypass surgery (%) 
Low risk 9.5 
Modemte risk 10.4 
High risk* 12.9 
Re~at PICA 4%) 
Low risk 15.7 
hbdemte risk 21.8 
High risk* 22.0 
Death 66) 
Low risk I.5 
Modemte risk 2.1 
Hi&risk* 5.0 
5 Yr 
5.3 
7.5 
8.2 
lb.3 
18.4 
27.0 
24.4 
32.2 
35.8 
5.2 
a.3 
19.5 
*Event fates at each time period were 
:ilsh risk patients cam 
~rcutaneQMs lm~sl~min~ coronary a~~~op~asty. 
have been defined (4J5.16). C 
ble angina, diabetes mellitus, 
have been shown to confer an i 
bidity and morality. in our patient pop 
gender was the only independent predictor 
event (risk ratio 1.3, 95% confidence interval 1.0 to 1.7). 
Wowever, male gender was found to be a predictor for late 
events. The gender differences may .reRe 
hood of disease progression in men, ahho 
aim et al. (1) assessed 
r patients undergoing coro- 
nary angioplasty in the setting of acute myocardial infarc- 
tion. Multivariate analysis was used to assess factors asso- 
ciated with worse event-free survival after coronary 
angioplasty. Although the patients in the Thrombolysis in
Myocardial Infarction I1 (TIM1 II) trial had coronary angio- 
plasty within 42 days of an acute myocardial infarction, 
baseline characteristics and event-free survival were re- 
markably similar to those of our results. Within 1 year, 
25.1% of patients in TIM1 II had an adverse vent after 
coronary angioplasty co d with 23.3% in our study. 
Events at 1 year in the study included 3.6% death, 
8.4% myocardial infarction, 11.2% bypass surgery and 
10.6% repeat coronary angioplasty. As expected, on the 
basis of the elective nature of the procedures inour study, 
events at 1 year were ‘less erious, with a higher incidence of
repeat coronary angioplasty (1.9% death, 1.5% myocardial 
infarction, 6.6% bypass urgery and 16.3% repeat coronary 
angioplasty). In the muhivarizte analysis, factors associated 
-..\ 
-...56.8% 
.'...I... 
..\..._...__ 
“'...._47.~% 
surviva9 after elective 
for event-free s~~iva9 
from the analysis. There were also a small number of elderly 
patients (I 1.7% >65 years of age). Despite the lower risk 
patients analyzed in the NHLBl registry, event rates were 
very high. In the first year, 48.5% of patients died or had 
myocardial infarction, bypass urgery or repeat coronary 
angioplasty (including in-hospital events). The majority of 
the patient riencing an event in the first year underwent 
bypass su (35.8%) or repeat corouary angioplasty 
(13.3%). For patients with an initially successful coronary 
angioplasty (63.4% of atients tudied), 59.4% had an event 
in the 1st 6 years. The high early event rate reflected a large 
number of patients undergoing bypass urgery during the 
initial hospital admission (24%). One-year event rates for 
patients in the 1985 to 1986 NHLBB registry were markedly 
improved, with only 5.7% of patients undergoing i~-hos~~ta9 
surgical revascularization and66% event free at 1 year (98). 
Our 1- and 5-year event rates are shown in Table 6. The 
results are interesting, in that he improved early event rates 
seen in the modem era most likely represent improvement i  
1 24 36 46 60 72 
Months Following PTCA 
LOW 1605 i3i)l 1152 897 607 312 
Med 1199 920 746 501 300 130 
High 95 470 347 205 97 35 
ica99y useful. A9thoMgb the 
simplified mode9 did have somewhat less predictive accu- 
curves for the three groups were 
1). The mode9 also allowed 
e individual end points, as 
shown in Table 4. Events at I and 5 years for each of the end 
points were significantly higher (p < 0.02) for high risk 
patients than for the low and moderate risk patients. The 
model is most useful in identifying patients at high risk for 
future cardiac events. Ahigh risk patient has a 35.6% chance 
of having an event in the first year and a 65.2% chance of 
having an event in the 1st 5 years. Alternatively, a low risk 
patient has a 23.7% chance of having an event in the 
year and a 39.2% chance of having an event in the 1 
edian event-free survival is 8.3 years for low rrs 
ared with 3.9 years for high 
facilitates risk stratification after elective angicplasty. The 
system could potentially be used to evaluate the relative 
merits of percutaneous versus urgical revascularization in 
future studies. As an example, a 78-year old woman with 
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double-vessel disease, previous coronary angioplasty and 
history of hypertension, diabetes mellitus and congestive 
failure would have a score of 11. Table 6 demonstrates he
risk for each of the end points at 1 and 5 years in this high 
risk patient. Although percutaneous revascularization may 
result in palliation of symptoms, she remains at high risk for 
subsequent cardiac events. Although similar data on loWterm 
event rates for patients undergoing bypass surgery would result 
in more rational decision making with regard to the appropriate 
treatment of such patients, urgical revascularization may 
result in an improved long-term event-free survival. 
s The present study deals with a statis- 
tical a large numher of patients. The 95% 
confidence intervals for the risk ratios are close to 1.0 for 
many of the variables, indicating that none of the factors 
alone places the patient at a high risk for a future vent. 
However, our multivariate model did allow accurate risk 
stratification byassessing the combined risks conferred by 
each of the variables. Any model’s predictive ability is best 
in the sample with which it was developed: thus, caution is 
advised when applying the results of the present study to 
other patient populations. Further, to develop a parsimoni- 
ous model, we only examined first-order terms and did not 
consider possible interactions between factors, although it is 
possible that some interactions exist. Finakly, it is possible 
that other modeling strategies, such as modeling risk factors 
for individual outcomes rather than combined outcomes, 
could have produced a series of predictive models &at, 
when combined, would hdve higher overall predictive ability 
than our final model. We chose to maximize the power of our 
study by combining end points to develop a single model that 
would simplify clinical use. 
CQ Because ofcontinued problems with resten- 
osis and progrkssion f the underlying disease, an increasing 
number of patients are returning for their second, third or 
fourth percutaneous revascularization procedure. Until 
now, few studies have attempted to identify clinical risk 
Factors that make apatient more likely to experience future 
cardiac events. Risk stratification f patients undergoing 
coronary an&oplasty may he useful in selection ofappropri- 
ate care and in directing patient care after the procedure. In 
the current study, we showed that clinical factors can be 
USed to risk-stratiFy long-term outccme. More important, 
patients identified ashi risk in the model had a very high rate 
of future cardiac events and may, in select cases, be better 
managed bysur&l revascularixation. c revigilant foilow-up 
d h&h risk patients could potentially lead to an improved 
outcome in this subgroup. Ultimately, only well designed 
randomized trials will be able to assess the relative merits and 
roles for the dilferent fomts of myocardial revas~ul~~ation. 
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